Article

Association between the use of levodopa/carbidopa and the disease outcomes included in the National Alzheimer’s Coordinating Center Uniform Data Set

2024-12-05

Abstract excerpt

<h4>INTRODUCTION</h4> This retrospective study investigates whether exposition to levodopa/carbidopa (LA/CA) medication is associated with modified Alzheimer’s disease (AD) trajectories. <h4>METHODS</h4> Multivariate analysis used cerebrospinal fluid (CSF) biomarker information included in the National Alzheimer’s Coordinating Center Uniform Data Set for subjects with normal cognition (NC), mild cognitive impairme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7bc6223d-8ba8-56e1-9458-f6bb3bcc8879
DOI: 10.1101/2024.12.04.24318183

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association between the use of levodopa/carbidopa and the disease outcomes included in the National Alzheimer’s Coordinating Center Uniform Data SetDOI 10.1101/2024.12.04.24318183Read

Medication Exposure and Neurodegenerative Disease Risk Across National BiobanksSemantic proximity Read

Effect of levodopa/carbidopa on the progression of Machado-Joseph disease /spinocerebellar ataxia type 3 (MJD/SCA3)Semantic proximity Read

An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM.Semantic proximity Read

Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.Semantic proximity Read

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.Semantic proximity Read

EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICASemantic proximity Read

Combination therapies delay cognitive decline over 10 years in Alzheimer’s NACC participantsSemantic proximity Read

Causal Connection Between Serum Levodopa Metabolic Profile and Medication in Parkinson’s DiseaseSemantic proximity Read

Potentially inappropriate medications related to two-year progression of mild cognitive impairment and dementiaSemantic proximity Read

Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studiesSemantic proximity Read

Associations between proton pump inhibitors and Alzheimer’s disease: A nested case-control study using a Korean nationwide health screening cohortSemantic proximity Read

Distinct medical and substance use histories associate with cognitive decline in Alzheimer’s DiseaseSemantic proximity Read